CorTec receives second FDA Breakthrough for Brain Interchange in communication for quadriplegia

CorTec/Brain Interchange

CorTec announced a second FDA Breakthrough designation for communication assistance in non-progressive quadriplegia, enabling patients with paralysis to control a computer cursor through neural signals.

• Second FDA Breakthrough designation for communication in non-progressive quadriplegia.
• Enables thought-controlled cursor movement for patients with four-limb paralysis.
• Single implant addresses both stroke recovery and communication assistance.
• Fully implanted wireless design eliminates percutaneous connector infection risk.